Efficacy and Tolerability of Lovastatin in 459 African-Americans With Hypercholesterolemia**This study was supported in part by grants to clinical sites from ClinTrials, Inc., Research Triangle Park, North Carolina, which was responsible for the execution of this study sponsored by Merck & Co, Inc., Rahway, New Jersey.-Reference-Cited by-同舟云学术

Efficacy and Tolerability of Lovastatin in 459 African-Americans With Hypercholesterolemia**This study was supported in part by grants to clinical sites from ClinTrials, Inc., Research Triangle Park, North Carolina, which was responsible for the execution of this study sponsored by Merck & Co, Inc., Rahway, New Jersey.

Published:1996-08 Issue:4 Volume:78 Page:420-424
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Prisant Michael L,Downton Maria,Watkins Laurence O,Schnaper Harold,Bradford Reagan H,Chremos Athanassios N,Langendörfer Alexandra

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference14 articles.

1. Second Report of the National Cholesterol Education Program Expert Panel on Detection. Evaluation, and Treatment of High blood cholesterol in Adults;JAMA,1993

2. Prevalence of high blood cholesterol among US adultws. An update based on guidelines from the second report of the National Cholesterol Education Program Adult Treatment Panel;Sempos;JAMA,1993

3. HMG-CoA reductase inhibitors for treatment of hypercholesterolemia;Grundy;N Engl J Med,1988

4. Expanded Clinical Evaluation of Lovastatin (EXCEL) Study: design and patient characteristics of a double-blind, placebo-controlled study in patients with moderate hypercholesteremia;Bradford;Am J Cardiol,1990

5. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge;Friedewald;Clin Chem,1972

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immigrants, Ethnicity, and Adherence to Secondary Cardiac Prevention Therapy: A Substudy of the ISLAND Trial;CJC Open;2021-07

2. Asymptomatic HyperCKemia;Managing Myositis;2019-12-15

3. Precision Medicine and Personalized Management of Lipoprotein and Lipid Disorders in Chronic and End-Stage Kidney Disease;Seminars in Nephrology;2018-07

4. Individualized risk for statin-induced myopathy: current knowledge, emerging challenges and potential solutions;Pharmacogenomics;2012-04

5. The Cost Effectiveness of Statin Therapies in Spain in 2010, after the Introduction of Generics and Reference Prices;American Journal Cardiovascular Drugs;2010-12